Sanofi
_cb-d9823d33005ac0d8f3c15c1064e0aa83.jpg)
Event: Partnerships in Drug Delivery
Phillips-Medisize will join Sanofi at the Partnerships in Drug Delivery (PODD) in Boston, Massachusetts on 5 October, 2015 more »
Sep 18, 2015 1:47 PM News
Sanofi and Google Life Sciences to improve diabetes health
Sanofi and the life sciences team at Google are teaming up to improve care and outcomes for people with type 1 and type 2 diabetes more »
Sep 1, 2015 2:39 PM News
Sanofi and Regeneron report successful Praluent trial
France's Sanofi and US partner Regeneron Pharmaceuticals have reported that the phase 3 trial of drug Praluent reduced cholesterol in 69% of Japanese patients in a phase 3 trial. more »
Jul 9, 2015 4:53 PM News
Sanofi and Medicines for Malaria to develop therapy
Sanofi will extend its alliance with Medicines for Malaria Venture to jointly develop a fixed-dose combination therapy for malaria, the deadliest parasitic disease in the world. more »
Jul 8, 2015 9:22 AM News
Japan approves Sanofi's new insulin injection for diabetes mellitus
The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. more »
Jul 6, 2015 12:51 PM News
FDA's EMDAC supports approval of alirocumab injection for hypercholesterolemia
Sanofi and Regeneron Pharmaceuticals have announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA recommended the approval of the investigational therapy Praluent (alirocumab) injection. more »
Jun 10, 2015 9:19 AM News
Niemann-Pick Type B treatment receives breakthrough therapy designation
Sanofi and subsidiary Genzyme have announced that the FDA has granted Breakthrough Therapy designation to olipudase alfa, an enzyme replacement therapy being investigated for the treatment of patients with non-neurological manifestations of ASMD... more »
Jun 4, 2015 2:54 PM News
Sanofi hosts Angela Merkel at Frankfurt site
German Chancellor Dr. Angela Merkel met with Sanofi chief executive officer Dr. Olivier Brandicourt to discuss the current status of antibiotics research and to gather ideas for encouraging and fostering additional antibiotics research initiatives. more »
May 28, 2015 4:24 PM News
Polyplus boss on Sanofi hire: Pharma CEO salaries "not politicians’ business"
Sanofi has taken on Pfizer/Bayer veteran Olivier Brandicourt as it's CEO - with, according to reports, a ‘golden handshake’ worth about $4.5 million. The French government calls this 'incomprehensible' - but one pharma boss disagrees. more »
Mar 5, 2015 12:01 PM Opinion
NHS "fundamentally flawed" says Sanofi amid cancer drugs cuts
Sanofi has spoken out about recent cuts to the UK's Cancer Drugs Fund, which will see at least two of its drugs delisted from March 12th. more »
Jan 13, 2015 10:11 AM News
Evotec and Sanofi form drug discovery agreement
Evotec has entered into exclusive negotiations with Sanofi on a major multi-component strategic alliance over the next five years. more »
Dec 10, 2014 10:08 AM News
Unilife/Sanofi wearables deal ‘unprecedented’, says Shortall
Unilife’s agreement with Sanofi to be the sole provider of cartridge based wearable injectors is ‘unprecedented’, according to Alan Shortall, Chairman and Chief Executive Officer at the firm. more »
Dec 1, 2014 4:43 PM News
Was Sanofi right to sack its CEO?
In a short statement, Sanofi’s board announced a unanimous decision to remove Chris Viehbacher as CEO. But speculators argue that the move may be mis-judged. more »
Oct 30, 2014 10:11 AM News
Sanofi chooses partner for ‘peel, stick and click’ injectors
Unilife Corporation has been chosen to act as the sole supplier of cartridge-based wearable injectors for all of Sanofi's applicable large dose volume drugs (excluding insulins). more »
Oct 13, 2014 3:39 PM Technology
Copyright: MannKind Corporation
Sanofi and MannKind announce global licensing agreement for Afrezza
The new rapid-acting inhaled insulin therapy is for treating adults with type 1 and type 2 diabetes. more »
Aug 14, 2014 12:55 PM
First antimalarial treatments produced with semisynthetic artemisinin enter market
The shipment signals a new era of lifesaving drugs made with safe, high-quality, and affordable artemisinin that is non-seasonal. more »
Aug 13, 2014 10:59 AM
FDA accepts Sanofi's NDA for basal insulin Toujeo
The acceptance of the NDA follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicines Agency (EMA) for EU countries on 27 May 2014. more »
Jul 10, 2014 12:44 PM
Sanofi facing triple threat from Eli Lilly for diabetes treatment market space
The imminent patent expiration of Sanofi’s Lantus has opened the door for Eli Lilly to increase its share of the diabetes treatment market more »
Jun 26, 2014 12:52 PM
Haselmeier announces launch of Sanofi half-unit insulin pen
Suitable for all Sanofi insulin types, the new and reusable half-unit insulin pen JuniorSTAR is now available in Germany. It provides individual dosage, which can be corrected easily. Furthermore, it has a large display to ensure the correct... more »
Apr 7, 2014 4:33 PM Technology
Phillips-Medisize Wins Supply Contract for Sanofi Injection Pen Components
Phillips-Medisize has signed a supply agreement for insulin pen components with Sanofi, a leader for diabetes treatment. As a result, injection pen component production at the plant in Kontiolahti, Finland, has been expanded with an automated... more »
Feb 4, 2014 9:31 AM Technology